Literature DB >> 32343993

RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.

Youssi M Athar1, Simpson Joseph2.   

Abstract

Fragile X syndrome is the most common form of inherited intellectual disability and is caused by a deficiency of the fragile X mental retardation protein (FMRP) in neurons. FMRP regulates the translation of numerous mRNAs within dendritic synapses, but how FMRP recognizes these target mRNAs remains unknown. FMRP has KH0, KH1, KH2, and RGG domains, which are thought to bind to specific RNA recognition elements (RREs). Several studies used high-throughput methods to identify various RREs in mRNAs that FMRP may bind to in vivo. However, there is little overlap in the mRNA targets identified by each study, suggesting that the RNA-binding specificity of FMRP is still unknown. To determine the specificity of FMRP for the RREs, we performed quantitative in vitroRNA binding studies with various constructs of human FMRP. Unexpectedly, our studies show that the KH domains do not bind to the previously identified RREs. To further investigate the RNA-binding specificity of FMRP, we developed a new method called Motif Identification by Analysis of Simple sequences (MIDAS) to identify single-stranded RNA sequences bound by KH domains. We find that the FMRP KH0, KH1, and KH2 domains bind weakly to the single-stranded RNA sequences suggesting that they may have evolved to bind more complex RNA structures. Additionally, we find that the RGG motif of human FMRP binds with a high affinity to an RNAG-quadruplex structure that lacks single-stranded loops, double-stranded stems, or junctions.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  KH domain; RGG domain; RNA G-quadruplex; fragile X mental retardation protein; fragile X syndrome

Mesh:

Substances:

Year:  2020        PMID: 32343993      PMCID: PMC7306444          DOI: 10.1016/j.jmb.2020.04.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  73 in total

1.  Solution structure of an unusually stable RNA tetraplex containing G- and U-quartet structures.

Authors:  C Cheong; P B Moore
Journal:  Biochemistry       Date:  1992-09-15       Impact factor: 3.162

Review 2.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Authors:  Michael R Santoro; Steven M Bray; Stephen T Warren
Journal:  Annu Rev Pathol       Date:  2011-10-10       Impact factor: 23.472

3.  Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.

Authors:  V Brown; P Jin; S Ceman; J C Darnell; W T O'Donnell; S A Tenenbaum; X Jin; Y Feng; K D Wilkinson; J D Keene; R B Darnell; S T Warren
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  Fragile X syndrome due to a missense mutation.

Authors:  Leila K Myrick; Mika Nakamoto-Kinoshita; Noralane M Lindor; Salman Kirmani; Xiaodong Cheng; Stephen T Warren
Journal:  Eur J Hum Genet       Date:  2014-01-22       Impact factor: 4.246

5.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

6.  Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA.

Authors:  Lakshmi Menon; Samantha Ann Mader; Mihaela-Rita Mihailescu
Journal:  RNA       Date:  2008-06-25       Impact factor: 4.942

7.  A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins.

Authors:  Akira Ishizuka; Mikiko C Siomi; Haruhiko Siomi
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

8.  Fragile X mental retardation protein interactions with a G quadruplex structure in the 3'-untranslated region of NR2B mRNA.

Authors:  Snezana Stefanovic; Brett A DeMarco; Ayana Underwood; Kathryn R Williams; Gary J Bassell; Mihaela Rita Mihailescu
Journal:  Mol Biosyst       Date:  2015-12

9.  Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs.

Authors:  Rachid Mazroui; Marc-Etienne Huot; Sandra Tremblay; Nathalie Boilard; Yves Labelle; Edouard W Khandjian
Journal:  Hum Mol Genet       Date:  2003-10-07       Impact factor: 6.150

10.  Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction.

Authors:  Anh Tuân Phan; Vitaly Kuryavyi; Jennifer C Darnell; Alexander Serganov; Ananya Majumdar; Serge Ilin; Tanya Raslin; Anna Polonskaia; Cynthia Chen; David Clain; Robert B Darnell; Dinshaw J Patel
Journal:  Nat Struct Mol Biol       Date:  2011-06-05       Impact factor: 15.369

View more
  6 in total

1.  The Human Fragile X Mental Retardation Protein Inhibits the Elongation Step of Translation through Its RGG and C-Terminal Domains.

Authors:  Youssi M Athar; Simpson Joseph
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

2.  The Fragile X Proteins Differentially Regulate Translation of Reporter mRNAs with G-quadruplex Structures.

Authors:  Madison Edwards; Simpson Joseph
Journal:  J Mol Biol       Date:  2021-12-08       Impact factor: 5.469

Review 3.  KH domain proteins: Another family of bacterial RNA matchmakers?

Authors:  Mikolaj Olejniczak; Xiaofang Jiang; Maciej M Basczok; Gisela Storz
Journal:  Mol Microbiol       Date:  2021-11-19       Impact factor: 3.979

4.  Genome-Wide Characterization and Expression Analysis of KH Family Genes Response to ABA and SA in Arabidopsis thaliana.

Authors:  Yanjie Zhang; Yu Ma; Ruiqi Liu; Guanglin Li
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

5.  FXS causing missense mutations disrupt FMRP granule formation, dynamics, and function.

Authors:  Emily L Starke; Keelan Zius; Scott A Barbee
Journal:  PLoS Genet       Date:  2022-02-24       Impact factor: 5.917

6.  A simple procedure for bacterial expression and purification of the fragile X protein family.

Authors:  Madison Edwards; Mingzhi Xu; Simpson Joseph
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.